Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2025-02-18 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a short notice informing the stock exchanges about the allotment of equity shares under the company's Employee Stock Option Plan (ESOP). It mentions the increase in paid-up equity share capital due to this allotment. The document is brief (1192 characters) and serves as an announcement of a capital change related to share allotment. It does not contain financial statements or detailed financial data, nor is it a report or presentation. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2025-02-18 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter addressed to stock exchanges (National Stock Exchange of India Limited and BSE Limited) referencing Regulation 30 & 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions the dispatch of a Postal Ballot Notice dated January 30, 2025, to the members of the company and encloses newspaper advertisements published on February 8, 2025. The content is primarily about notifying the exchanges of the publication of advertisements related to the postal ballot process. There is no substantive financial data, management discussion, or detailed report content. The document is essentially an announcement of the dispatch and publication of notices, not the report or ballot results themselves. Given the nature of the document as an announcement related to shareholder voting materials, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is about the dispatch of the Postal Ballot Notice (which is a solicitation for votes), it aligns more closely with Proxy Solicitation & Information Statement (PSI). Therefore, the classification is PSI with high confidence.
2025-02-08 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice issued by Dr. Lal PathLabs Limited dated February 7, 2025. It references the Companies Act, 2013, SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and Ministry of Corporate Affairs circulars. The notice seeks shareholder approval for a special resolution regarding payment of commission to Non-Executive Directors including Independent Directors via remote e-voting. It includes detailed instructions on voting procedures, cut-off dates, and timelines for e-voting and result announcement. The document is a formal notice to shareholders to vote on a resolution remotely, not the announcement of voting results or the report of the vote outcome. It is not a full annual or interim report, earnings release, or management discussion. It is also not a proxy solicitation or remuneration report but a notice for a postal ballot vote. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) only if it contained the results, but since it is the notice before voting, it is best classified as a Proxy Solicitation & Information Statement (PSI) because it solicits votes and provides information for shareholders to vote on a resolution via postal ballot.
2025-02-07 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an update on the voluntary liquidation of a wholly owned subsidiary, Suburban Diagnostics (India) Private Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is an announcement of a corporate action (liquidation approval by members) rather than a detailed financial report or audit. It is not a full report but a regulatory disclosure about a corporate event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q3 FY25 earnings conference call for Dr. Lal PathLabs. It includes management presentations, financial performance highlights, operational updates, and a Q&A session with analysts and investors. The text explicitly mentions it is a transcript of the earnings call, with detailed financial data such as revenue, EBITDA, PAT, EPS, and operational metrics. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls including earnings calls with Q&A. The document is not a brief earnings release (ER) or an investor presentation (IP), but a full transcript. Therefore, the correct classification is CT with high confidence.
2025-02-03 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited and BSE Limited, referencing the publication of newspaper advertisements of the company's financial results for the quarter and nine months ended December 31, 2024. It mentions compliance with SEBI regulations and encloses copies of the newspaper advertisements. The document does not contain the actual financial results or detailed financial statements but rather is an announcement that the financial results have been published in newspapers. The length of the document is about 13,353 characters, but the content is primarily an announcement of the publication of financial results, not the results themselves. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2025-01-31 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.